Loading...

Osteopore Limited

OSX.AX•ASX
Healthcare
Medical - Instruments & Supplies
A$0.01
A$0.00(0.00%)

Osteopore Limited (OSX.AX) Stock Overview

Explore Osteopore Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

F

Score: N/A

Key Financials

Market Cap2.2M
P/E Ratio-0.31
EPS (TTM)$-0.04
ROE-3.08%
Fundamental Analysis

AI Price Forecasts

1 Week$0.02
1 Month$0.01
3 Months$0.28
1 Year Target$0.11

OSX.AX Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Osteopore Limited (OSX.AX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.63, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.11.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.31 and a market capitalization of 2.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Technical Indicators

40.63RSI (14)
0.00MACD
12.02ADX
Revenue Growth
26.79%
↑ 26.79%
Profit Growth
A$-0.03
↑ 33.40%
EPS Growth
A$-0.03
↑ 64.41%
Operating Margin
-91.87%
↑ 41.52%
ROE
-307.58%
↑ 33.40%
Dividend Yield
0.00%
Analyst Recommendations data is not available for OSX.AXAnalyst Recommendations details for OSX.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Osteopore Limited designs, develops, and markets bioresorbable polymer implants for neurosurgical, orthopedic, and maxillofacial surgery applications in Singapore, Australia, and internationally. Its technology fabricates specific micro-structured scaffolds for bone regeneration through 3D printing and bioresorbable material. The company offers Osteoplug, a bioresorbable implant, which is used for covering trephination burr holes in neurosurgery; and Osteomesh, a bioresorbable implant that is used in craniofacial surgery to repair various types of fractures, such as orbital floor fracture, as well as to fill surgical defects. Osteopore Limited has a collaboration agreement with Livingstone Health Holding Limited to jointly develop new applications and products for regenerating bone and tissue. The company was incorporated in 2003 and is headquartered in Singapore.

CEO

Yujing Lim

Headquarters

No. 09-06, 2 Tukang Innovation Grove, Singapore

Founded

2019

Frequently Asked Questions

;